These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9004055)

  • 1. Methamphetamine psychosis: spontaneous recurrence of paranoid-hallucinatory states and monoamine neurotransmitter function.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    J Clin Psychopharmacol; 1997 Feb; 17(1):34-43. PubMed ID: 9004055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine neurotransmitter function and spontaneous recurrence of methamphetamine psychosis.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    Ann N Y Acad Sci; 1996 Oct; 801():415-29. PubMed ID: 8959056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis: noradrenergic hyperactivity with contribution from dopaminergic hyperactivity.
    Yui K; Goto K; Ikemoto S; Ishiguro T; Kamata Y
    J Clin Psychopharmacol; 2000 Apr; 20(2):165-74. PubMed ID: 10770454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects: susceptibility to psychotic states and implications for relapse of schizophrenia.
    Yui K; Ikemoto S; Goto K; Nishijima K; Yoshino T; Ishiguro T
    Pharmacopsychiatry; 2002 Mar; 35(2):62-71. PubMed ID: 11951147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous recurrence of methamphetamine psychosis: process and monoamine neurotransmitter function.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Aug; 15(4):363-74. PubMed ID: 7584731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the development of spontaneous recurrence of methamphetamine psychosis.
    Yui K; Ishiguro T; Goto K; Ikemoto S
    Acta Psychiatr Scand; 1998 Mar; 97(3):220-7. PubMed ID: 9543311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenergic activity and spontaneous recurrence of methamphetamine psychosis.
    Yui K; Goto K; Ishiguro T; Ikemoto S
    Drug Alcohol Depend; 1997 Mar; 44(2-3):183-7. PubMed ID: 9088791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma monoamine metabolites and spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory psychosis: relation of noradrenergic activity to the occurrence of flashbacks.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    Psychiatry Res; 1996 Jul; 63(2-3):93-107. PubMed ID: 8878306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to subsequent episodes in spontaneous recurrence of methamphetamine psychosis.
    Yui K; Ishiguro T; Goto K; Ikemoto S
    Ann N Y Acad Sci; 2000 Sep; 914():292-302. PubMed ID: 11085329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine neurotransmitter metabolites and spontaneous recurrence of methamphetamine psychosis.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    Brain Res Bull; 1997; 43(1):25-33. PubMed ID: 9205790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change.
    Yui K; Ishiguro T; Goto K; Ikemoto S; Kamata Y
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(2):103-11. PubMed ID: 10369157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    Drug Alcohol Depend; 2000 Feb; 58(1-2):67-75. PubMed ID: 10669056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of noradrenergic and dopaminergic hyperactivity in the development of spontaneous recurrence of methamphetamine psychosis and susceptibility to episode recurrence.
    Yui K; Goto K; Ikemoto S
    Ann N Y Acad Sci; 2004 Oct; 1025():296-306. PubMed ID: 15542730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis.
    Yui K; Ikemoto S; Goto K
    Ann N Y Acad Sci; 2002 Jun; 965():292-304. PubMed ID: 12105105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity to stress and episode recurrence in spontaneous recurrence of methamphetamine psychosis.
    Yui K; Goto K; Ikemoto S; Ishiguro T; Kamada Y
    Psychopharmacology (Berl); 1999 Aug; 145(3):267-72. PubMed ID: 10494575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precipitating factors in spontaneous recurrence of methamphetamine psychosis.
    Yui K; Ishiguro T; Goto K; Ikemoto S
    Psychopharmacology (Berl); 1997 Dec; 134(3):303-8. PubMed ID: 9438680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis.
    Yui K; Goto K; Ikemoto S; Nishijima K; Yoshino T; Ishiguro T
    Drug Alcohol Depend; 2001 Oct; 64(2):133-42. PubMed ID: 11543983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity to stress associated with noradrenergic hyperactivity, involving dopaminergic hyperactivity in spontaneous recurrences in methamphetamine psychosis.
    Yui K; Goto K; Ikemoto S; Jima KN; Kamada Y; Ishiguro T
    Addict Biol; 2000 Jul; 5(3):343-50. PubMed ID: 20575851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis.
    Sato M
    Ann N Y Acad Sci; 1992 Jun; 654():160-70. PubMed ID: 1632581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.
    Yui K; Ikemoto S; Ishiguro T; Goto K
    Ann N Y Acad Sci; 2000 Sep; 914():1-12. PubMed ID: 11085303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.